Cherishing the Simple Things
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random and not inherited by her children.
Where Sorrow and Joy Meet
Musician and producer Tom Bajoras has focused on the sorrow, joy, and beauty of life as he fights PNET with standard and new treatments.
Harnessing the Power of Radionuclide Therapy
Julie Sutcliffe is working with targeted radionuclide therapy to go after pancreatic cancer cells that have spread beyond the pancreas.
Pitching a Perfect Game Against Pancreatic Cancer
Andy Spiteri is a fantasy sports enthusiast, so he turned to his favorite activity to help him through pancreatic cancer treatment.
Twice Facing Pancreatic Cancer
Steven Lewis has faced down pancreatic cancer twice–first with a Whipple, CyberKnife, and chemoradiation; then with liver surgery for metastasis.
Immunology Researchers Solve a Mystery of Metastasis
Physician and researcher Douglas Fearon and his lab have a possible explanation for how cancer cells metastasize, and the role surgery may play in this process.
Mechanism of Metastasis Is Discovered in Pancreatic Cancer
The Foundation’s dedicated lab at Cold Spring Harbor Laboratory (CSHL) used organoid technology to find that pancreatic cancer cells reprogram gene enhancers to achieve the ability to spread. The research, appearing online on August 8, 2017, in Cell, provides strong evidence supporting this explanation of metastasis, which is the cause of most cancer deaths. Experiments…
Taking a Different Approach to Pancreatic Cancer Treatment
When Dr. Steve Bigelsen was diagnosed with stage IV pancreatic cancer, chemosensitivity testing led him to treatments beyond standard of care.